Stock Earnings

Question 1

What are Ligand Pharmaceuticals Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Ligand Pharmaceuticals Inc has a total asset of $941, Net loss of $-4

Question 2

What are the key financial ratios for LGNZZ?

Accepted Answer

Ligand Pharmaceuticals Inc's Current ratio is 8.47, has a Net margin is -2.39, sales per share of $9.13.

Question 3

How is Ligand Pharmaceuticals Inc's revenue broken down by segment or geography?

Accepted Answer

Ligand Pharmaceuticals Inc largest revenue segment is Biopharmaceutical, at a revenue of 167,133,000 in the most earnings release.For geography, United States is the primary market for Ligand Pharmaceuticals Inc, at a revenue of 167,133,000.

Question 4

Is Ligand Pharmaceuticals Inc profitable?

Accepted Answer

no, according to the latest financial statements, Ligand Pharmaceuticals Inc has a net loss of $-4

Question 5

Does Ligand Pharmaceuticals Inc have any liabilities?

Accepted Answer

yes, Ligand Pharmaceuticals Inc has liability of 111

Question 6

How many outstanding shares for Ligand Pharmaceuticals Inc?

Accepted Answer

Ligand Pharmaceuticals Inc has a total outstanding shares of 19.1

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	251	167	131	196	277	186
Revenue Growth (YoY)	65%	27%	-33%	-28.99%	49%	55%
Cost of Revenue	14	11	10	52	62	30
Gross Profit	236	156	120	143	215	156
Selling, General & Admin	93	78	52	70	57	64
Research & Development	82	21	24	36	69	59
Operating Expenses	207	133	110	140	136	147
Other Non Operating Income (Expenses)	-8	-54	-2	0	-1	0
Pretax Income	62	2	63	36	47	-10
Income Tax Expense	14	6	9	41	-9	-7
Net Income	48	-4	52	-33	57	-3
Net Income Growth	7%	-108%	-258%	-158%	-2,000%	-100%
Shares Outstanding (Diluted)	20.62	18.29	17.75	16.9	17.2	16.2
Shares Change (YoY)	12%	3%	5%	-2%	6%	-18%
EPS (Diluted)	2.35	-0.22	2.93	-1.97	3.31	-0.18
EPS Growth	-4%	-108%	-249%	-160%	-1,939%	-101%
Free Cash Flow	30	95	-14	120	70	50
Free Cash Flow Per Share	1.45	5.19	-0.78	7.1	4.06	3.08
Gross Margin	94.02%	93.41%	91.6%	72.95%	77.61%	83.87%
Operating Margin	11.15%	13.77%	6.87%	1.53%	28.15%	4.3%
Profit Margin	19.12%	-2.39%	39.69%	-16.83%	20.57%	-1.61%
Free Cash Flow Margin	11.95%	56.88%	-10.68%	61.22%	25.27%	26.88%
EBITDA	62	58	45	54	129	33
EBITDA Margin	24.7%	34.73%	34.35%	27.55%	46.57%	17.74%
D&A For EBITDA	34	35	36	51	51	25
EBIT	28	23	9	3	78	8
EBIT Margin	11.15%	13.77%	6.87%	1.53%	28.15%	4.3%
Effective Tax Rate	22.58%	300%	14.28%	113.88%	-19.14%	70%

Ligand Pharmaceuticals Inc (LGNZZ) Price

LGNZZ Stock Price Chart

LGNZZ Income

Follow-Up Questions